185 related articles for article (PubMed ID: 38151621)
1. Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis.
Robbins KJ; Newcomer KF; Barnell EK; Anzelmo MA; Liu J; Hawkins WG
Ann Surg Oncol; 2024 May; 31(5):2873-2881. PubMed ID: 38151621
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
[TBL] [Abstract][Full Text] [Related]
3. Perioperative Blood Transfusions Are Associated with a Higher Incidence of Thromboembolic Events After TKA: An Analysis of 333,463 TKAs.
Acuña AJ; Grits D; Samuel LT; Emara AK; Kamath AF
Clin Orthop Relat Res; 2021 Mar; 479(3):589-600. PubMed ID: 33165044
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
[TBL] [Abstract][Full Text] [Related]
5. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
Boone BA; Zenati MS; Rieser C; Hamad A; Al-Abbas A; Zureikat AH; Hogg ME; Neal MD; Zeh HJ
Ann Surg Oncol; 2019 May; 26(5):1503-1511. PubMed ID: 30652227
[TBL] [Abstract][Full Text] [Related]
6. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.
Sloan M; Sheth N; Lee GC
Clin Orthop Relat Res; 2019 Mar; 477(3):523-532. PubMed ID: 30624321
[TBL] [Abstract][Full Text] [Related]
7. Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry.
Goel R; Patel EU; Cushing MM; Frank SM; Ness PM; Takemoto CM; Vasovic LV; Sheth S; Nellis ME; Shaz B; Tobian AAR
JAMA Surg; 2018 Sep; 153(9):826-833. PubMed ID: 29898202
[TBL] [Abstract][Full Text] [Related]
8. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy.
Hank T; Sandini M; Ferrone CR; Rodrigues C; Weniger M; Qadan M; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
JAMA Surg; 2019 Oct; 154(10):943-951. PubMed ID: 31411659
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer.
Yoshitomi H; Sakai N; Kagawa S; Takano S; Ueda A; Kato A; Furukawa K; Takayashiki T; Kuboki S; Miyzaki M; Ohtsuka M
Langenbecks Arch Surg; 2019 Jun; 404(4):451-458. PubMed ID: 30868241
[TBL] [Abstract][Full Text] [Related]
10. Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive approach.
Sood D; Kuchta K; Paterakos P; Schwarz JL; Rojas A; Choi SH; Vining CC; Talamonti MS; Hogg ME
J Surg Oncol; 2023 Mar; 127(3):413-425. PubMed ID: 36367398
[TBL] [Abstract][Full Text] [Related]
11. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Therapy for Pancreatic Cancer: Increased Use and Improved Optimal Outcomes.
Davis CH; Beane JD; Gazivoda VP; Grandhi MS; Greenbaum AA; Kennedy TJ; Langan RC; August DA; Alexander HR; Pitt HA
J Am Coll Surg; 2022 Apr; 234(4):436-443. PubMed ID: 35290262
[TBL] [Abstract][Full Text] [Related]
13. Minimally Invasive Surgery is Associated with an Increased Risk of Postoperative Venous Thromboembolism After Distal Pancreatectomy.
Willobee BA; Dosch AR; Allen CJ; Macedo FI; Bartholomew TS; Picado O; Gaidarski AA; Dudeja V; Yakoub D; Merchant NB
Ann Surg Oncol; 2020 Jul; 27(7):2498-2505. PubMed ID: 31919713
[TBL] [Abstract][Full Text] [Related]
14. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
Nassour I; Adam MA; Kowalsky S; Al Masri S; Bahary N; Singhi AD; Lee K; Zureikat A; Paniccia A
J Surg Oncol; 2021 Jan; 123(1):245-251. PubMed ID: 33103242
[TBL] [Abstract][Full Text] [Related]
16. Red Blood Cell Transfusions and Risk of Postoperative Venous Thromboembolism.
Sheth BK; Yakkanti R; Ravipati K; Arif B; Castro G; Hernandez V
J Am Acad Orthop Surg; 2022 Jul; 30(13):e919-e928. PubMed ID: 35439203
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
Chong W; Bui AH; Menhaji K
Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
Czosnyka NM; Borgert AJ; Smith TJ
HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.
Ivey GD; Shoucair S; Delitto DJ; Habib JR; Kinny-Köster B; Shubert CR; Lafaro KJ; Cameron JL; Burns WR; Burkhart RA; Thompson EL; Narang A; Zheng L; Wolfgang CL; He J
World J Surg; 2022 Nov; 46(11):2751-2759. PubMed ID: 35861852
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism risk for the contemporary bariatric surgeon.
Gambhir S; Inaba CS; Alizadeh RF; Nahmias J; Hinojosa M; Smith BR; Nguyen NT; Daly S
Surg Endosc; 2020 Aug; 34(8):3521-3526. PubMed ID: 31559578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
